Hanaa El Gendy
Cairo, Ain Shams University Specialized Hospital, Egypt
NCT Number: NCT04067739
Liver transplantation is the only definitive treatment for end stage liver disease. Being a major abdominal surgery, may have postoperative complications that require readmission, which may be serious and life threatening. In general, patients who required ICU readmission showed higher morbidity, mortality and prolonged hospital stay compared to those who did not require readmission. We will conduct this retrospective observational study to identify incidence, causes and outcomes of ICU readmission after LDLT
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cairo, Ain Shams University Specialized Hospital, Egypt
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
non interventional study
Time frame: within 3 months
Incidence, causes and outcomes of ICU readmission within ≤ 3 months of initial ICU discharge
Time frame: Within 3 months
comparison between one year survival in both groups
Ain Shams University
Other
ICU Readmission in Adult Egyptian Patients Undergoing Living Donor Liver Transplant: Incidence, Causes and Outcomes: A Single Centre Retrospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.